CARILLON TOWER ADVISERS, INC. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 275 filers reported holding HAEMONETICS CORP in Q3 2019. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
CARILLON TOWER ADVISERS, INC. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2020$31,588,011,000
-20.3%
344,7720.0%0.31%
+17.0%
Q4 2019$39,614,303,000
+73945.4%
344,772
-18.7%
0.26%
-29.0%
Q3 2019$53,500,000
+4.8%
424,1330.0%0.37%
+6.3%
Q2 2019$51,040,000
+37.6%
424,1330.0%0.35%
+33.5%
Q1 2019$37,103,000
-12.6%
424,1330.0%0.26%
-26.7%
Q4 2018$42,434,000
-12.7%
424,1330.0%0.36%
+3.2%
Q3 2018$48,597,000424,1330.35%
Other shareholders
HAEMONETICS CORP shareholders Q3 2019
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders